Recent Updates
Recently added Catalysts
INKT Positive Sentiment Score: 60/100

MiNK Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results

Tuesday, March 7, 2023 1 min read
Key Takeaway: MiNK Therapeutics, a clinical-stage biopharmaceutical company, announced that it will release its financial results for Q4 and the full year of 2022 on March 21, 2023. The company specializes in developing iNKT cell therapies aimed at treating cancer and immune-mediated diseases. During the announcement, MiNK's leadership will host a conference call at 8:30 a.m. ET to discuss these results and provide a corporate update. This indicates proactive investor communication and commitment to transparency.

Market Sentiment Analysis

POSITIVE FACTORS

  • MiNK Therapeutics is preparing to report its financial results.
  • The company is actively engaging with investors through a conference call.
  • They are pioneering the development of innovative cancer therapies.

Full Press Release Details

NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, today announced that the Company will release its fourth quarter and full year 2022 financial results before the market opens on Tuesday, March 21, 2023. Members of the MiNK leadership team will host a conference call and webcast at 8:30 a.m. ET that morning to discuss the results and to provide a corporate update.
Dial in numbers: 646-307-1963 (USA-NY), 800-715-9871 (USA & Canada)
Conference ID: 6075772
A live webcast and replay of the conference call will be accessible from the Events & Presentations page of the Company’s website at https://investor.minktherapeutics.com/events-and-presentations and via https://edge.media-server.com/mmc/p/ctv5wn5g.
About MiNK Therapeutics
communications@minktherapeutics.com
investor@minktherapeutics.com

Frequently Asked Questions

When will MiNK Therapeutics announce financial results for Q4 2022?

MiNK Therapeutics will announce its Q4 and full year 2022 financial results on March 21, 2023.

What time is the MiNK Therapeutics conference call?

The conference call will take place at 8:30 a.m. ET on March 21, 2023.

How can I access the MiNK Therapeutics conference call?

You can join the call by dialing 646-307-1963 or 800-715-9871.

Where can I find the webcast of the MiNK conference call?

The live webcast will be available on the Events & Presentations page of MiNK's website.

What type of therapies does MiNK Therapeutics develop?

MiNK Therapeutics develops allogeneic, off-the-shelf, invariant natural killer T cell therapies.

Tags: INKT Viatris Investor Conferences Healthcare MiNK Therapeutics financial results Q4 2022 iNKT cell therapies clinical-stage biopharmaceutical
Last updated: Mar 7, 2023